929 related articles for article (PubMed ID: 16389718)
1. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.
Zimmermann U; Kraus T; Himmerich H; Schuld A; Pollmächer T
J Psychiatr Res; 2003; 37(3):193-220. PubMed ID: 12650740
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population.
Choong E; Bondolfi G; Etter M; Jermann F; Aubry JM; Bartolomei J; Gholam-Rezaee M; Eap CB
J Psychiatr Res; 2012 Apr; 46(4):540-8. PubMed ID: 22316639
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
8. Weight considerations in psychotropic drug prescribing and switching.
Hasnain M; Vieweg WV
Postgrad Med; 2013 Sep; 125(5):117-29. PubMed ID: 24113670
[TBL] [Abstract][Full Text] [Related]
9. Induction of obesity by psychotropic drugs.
Bernstein JG
Ann N Y Acad Sci; 1987; 499():203-15. PubMed ID: 2886102
[TBL] [Abstract][Full Text] [Related]
10. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
11. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.
Pijl H; Meinders AE
Drug Saf; 1996 May; 14(5):329-42. PubMed ID: 8800628
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric medication-induced obesity: a review.
Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
[TBL] [Abstract][Full Text] [Related]
14. An epidemiologic study of psychotropic medication and obesity-related chronic illnesses in older psychiatric patients.
Kisely S; Cox M; Campbell LA; Cooke C; Gardner D
Can J Psychiatry; 2009 Apr; 54(4):269-74. PubMed ID: 19321033
[TBL] [Abstract][Full Text] [Related]
15. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
16. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced weight gain.
Ness-Abramof R; Apovian CM
Drugs Today (Barc); 2005 Aug; 41(8):547-55. PubMed ID: 16234878
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study.
Barton BB; Zagler A; Engl K; Rihs L; Musil R
Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):597-609. PubMed ID: 31302731
[TBL] [Abstract][Full Text] [Related]
19. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
20. Metabolic disorders induced by psychotropic drugs.
Scheen AJ
Ann Endocrinol (Paris); 2023 May; 84(3):357-363. PubMed ID: 36963753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
